MAI Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,189
Closed -$218K 865
2021
Q2
$218K Buy
+1,189
New +$204K ﹤0.01% 682
2021
Q1
Sell
-1,754
Closed -$274K 790
2020
Q4
$274K Sell
1,754
-354
-17% -$45.5K 0.01% 556
2020
Q3
$241K Sell
2,108
-612
-23% -$66K 0.01% 510
2020
Q2
$305K Sell
2,720
-225
-8% -$23.9K 0.01% 455
2020
Q1
$264K Sell
2,945
-1,317
-31% -$129K 0.01% 455
2019
Q4
$461K Sell
4,262
-2,507
-37% -$268K 0.02% 402
2019
Q3
$663K Sell
6,769
-292
-4% -$32.9K 0.03% 310
2019
Q2
$925K Buy
+7,061
New +$910K 0.04% 255
2017
Q2
Sell
-1,682
Closed -$204K 477
2017
Q1
$204K Sell
1,682
-3,028
-64% -$390K 0.01% 414
2016
Q4
$576K Sell
4,710
-491
-9% -$60.1K 0.04% 247
2016
Q3
$637K Buy
5,201
+920
+21% +$118K 0.05% 240
2016
Q2
$500K Buy
4,281
+1,358
+46% +$193K 0.04% 271
2016
Q1
$407K Buy
2,923
+273
+10% +$40.1K 0.03% 295
2015
Q4
$505K Buy
2,650
+596
+29% +$104K 0.04% 270
2015
Q3
$321K Buy
2,054
+549
+36% +$100K 0.02% 334
2015
Q2
$272K Buy
+1,505
New +$260K 0.02% 386

Other funds holding ALXN